Company Progenics Pharmaceuticals, Inc.
Equities
US7431871067
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 86,796,000 | 85,730,040 ( 98.77 %) | 200,000 ( 0.2304 %) | 98.77 % |
Company contact information
Progenics Pharmaceuticals, Inc.
One World Trade Center 47th floor
10007-0089, New York
+
http://www.progenics.com![address Progenics Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/10461.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |